These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

939 related items for PubMed ID: 9533540

  • 1. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
    McLeskey SW, Zhang L, El-Ashry D, Trock BJ, Lopez CA, Kharbanda S, Tobias CA, Lorant LA, Hannum RS, Dickson RB, Kern FG.
    Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540
    [Abstract] [Full Text] [Related]

  • 2. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ, Jelovac D, Thiantanawat A, Brodie AM.
    Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
    [Abstract] [Full Text] [Related]

  • 3. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
    Zhang L, Kharbanda S, Hanfelt J, Kern FG.
    Cancer Res; 1998 Jan 15; 58(2):352-61. PubMed ID: 9443417
    [Abstract] [Full Text] [Related]

  • 4. Aromatase and breast cancer.
    Brodie A, Sabnis G, Jelovac D.
    J Steroid Biochem Mol Biol; 2006 Dec 15; 102(1-5):97-102. PubMed ID: 17113978
    [Abstract] [Full Text] [Related]

  • 5. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N, Boysen B, Jirus S, Skaar TC, Holst-Hansen C, Lippman J, Frandsen T, Spang-Thomsen M, Fuqua SA, Clarke R.
    Cancer Res; 1997 Aug 15; 57(16):3486-93. PubMed ID: 9270017
    [Abstract] [Full Text] [Related]

  • 6. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
    Herman ME, Katzenellenbogen BS.
    J Steroid Biochem Mol Biol; 1996 Oct 15; 59(2):121-34. PubMed ID: 9010327
    [Abstract] [Full Text] [Related]

  • 7. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
    McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG.
    Cancer Res; 1993 May 01; 53(9):2168-77. PubMed ID: 8481920
    [Abstract] [Full Text] [Related]

  • 8. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J, Otsuki T, Yamamoto S, Kurosumi M, Nakata T, Akinaga S, Sonoo H.
    Oncology; 1998 Dec 01; 55 Suppl 1():23-34. PubMed ID: 9852399
    [Abstract] [Full Text] [Related]

  • 9. Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer.
    Núñez NP, Jelovac D, Macedo L, Berrigan D, Perkins SN, Hursting SD, Barrett JC, Brodie A.
    Clin Cancer Res; 2004 Aug 15; 10(16):5375-80. PubMed ID: 15328175
    [Abstract] [Full Text] [Related]

  • 10. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE, Madsen MW, Briand P.
    Cancer Res; 1994 Mar 15; 54(6):1587-95. PubMed ID: 8137264
    [Abstract] [Full Text] [Related]

  • 11. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV, Sun Y, Westbrook L, Rentz SS, Manuvakhova M, Qu Z, Samuel S, Upshaw R, Cunningham A, Kern FG.
    Cancer Res; 2004 Jul 01; 64(13):4637-47. PubMed ID: 15231676
    [Abstract] [Full Text] [Related]

  • 12. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ, Raney S.
    Cell Biol Int; 1998 Jul 01; 22(6):413-9. PubMed ID: 10328849
    [Abstract] [Full Text] [Related]

  • 13. Model systems: mechanisms involved in the loss of sensitivity to letrozole.
    Brodie A, Jelovac D, Sabnis G, Long B, Macedo L, Goloubeva O.
    J Steroid Biochem Mol Biol; 2005 May 01; 95(1-5):41-8. PubMed ID: 15967659
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic observations in MCF-7 aromatase xenografts.
    Brodie A, Jelovac D, Macedo L, Sabnis G, Tilghman S, Goloubeva O.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 2):884s-8s. PubMed ID: 15701882
    [Abstract] [Full Text] [Related]

  • 15. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
    Osipo C, Gajdos C, Cheng D, Jordan VC.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):249-56. PubMed ID: 15860267
    [Abstract] [Full Text] [Related]

  • 16. Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors.
    Johnston SR, Lu B, Dowsett M, Liang X, Kaufmann M, Scott GK, Osborne CK, Benz CC.
    Cancer Res; 1997 Sep 01; 57(17):3723-7. PubMed ID: 9288779
    [Abstract] [Full Text] [Related]

  • 17. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB.
    Oncogene; 2002 Jun 06; 21(25):4000-8. PubMed ID: 12037682
    [Abstract] [Full Text] [Related]

  • 18. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness.
    Larsen SS, Madsen MW, Jensen BL, Lykkesfeldt AE.
    Int J Cancer; 1997 Sep 17; 72(6):1129-36. PubMed ID: 9378550
    [Abstract] [Full Text] [Related]

  • 19. MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice.
    Zhang L, Kharbanda S, Chen D, Bullocks J, Miller DL, Ding IY, Hanfelt J, McLeskey SW, Kern FG.
    Oncogene; 1997 Oct 23; 15(17):2093-108. PubMed ID: 9366526
    [Abstract] [Full Text] [Related]

  • 20. Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity.
    Dumont JA, Bitonti AJ, Wallace CD, Baumann RJ, Cashman EA, Cross-Doersen DE.
    Cell Growth Differ; 1996 Mar 23; 7(3):351-9. PubMed ID: 8838865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.